In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 3rd, 2008 | 12 | Yes |
Popular Name: 2,3-Dihydroxyquinoxaline 2,3-Dihydroxyquinoxaline
Find On: PubMed — Wikipedia — Google
CAS Numbers: , 15804-19-0 , 6287-20-3 , [15804-19-0]
1,2,3,4-tetrahydroquinoxaline-2,3-dione
1,4-dihydro-2,3-quinoxalinedione
1,4-dihydroquinoxaline-2,3-dione
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | -0.27 | 1.48 | -11.66 | 2 | 4 | 0 | 66 | 162.148 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
MP | 16 - 18 | Enamine Building Blocks |
MP | 16...18 | Enamine Building Blocks |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 95% | Fluorochem |
mp | >250 | MolMall (formerly Molecular Diversity Preservation International) |
Melting_Point | >300? | Alfa-Aesar |
MP | >300° | Oakwood Chemical |
PUBCHEM_PATENT_ID | EP0794953A1; EP0794953B1; EP0853617A1; EP0869791A1; US4042577; US5955464; US6080743; US6124317; US6124323; US6130234; US6153591; WO1996016960A1; WO1997008155A1; WO1997023214A1; WO1997023215A1; WO1997023216A1; WO1999047154A1; WO2000050419A1 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GRID1-1-E | Glutamate Receptor Delta-1 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9800 | 0.58 | Binding ≤ 10μM |
NMD3A-5-E | Glutamate [NMDA] Receptor Subunit 3A (cluster #5 Of 6), Eukaryotic | Eukaryotes | 9800 | 0.58 | Binding ≤ 10μM |
NMD3B-5-E | Glutamate [NMDA] Receptor Subunit 3B (cluster #5 Of 6), Eukaryotic | Eukaryotes | 9800 | 0.58 | Binding ≤ 10μM |
NMDE1-3-E | Glutamate [NMDA] Receptor Subunit Epsilon 1 (cluster #3 Of 5), Eukaryotic | Eukaryotes | 9800 | 0.58 | Binding ≤ 10μM |
NMDE2-3-E | Glutamate [NMDA] Receptor Subunit Epsilon 2 (cluster #3 Of 5), Eukaryotic | Eukaryotes | 9800 | 0.58 | Binding ≤ 10μM |
NMDE3-2-E | Glutamate [NMDA] Receptor Subunit Epsilon 3 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 9800 | 0.58 | Binding ≤ 10μM |
NMDE4-5-E | Glutamate [NMDA] Receptor Subunit Epsilon 4 (cluster #5 Of 6), Eukaryotic | Eukaryotes | 9800 | 0.58 | Binding ≤ 10μM |
NMDZ1-3-E | Glutamate (NMDA) Receptor Subunit Zeta 1 (cluster #3 Of 6), Eukaryotic | Eukaryotes | 9800 | 0.58 | Binding ≤ 10μM |
Z104302-4-O | Glutamate NMDA Receptor (cluster #4 Of 7), Other | Other | 9800 | 0.58 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
NMDZ1_HUMAN | Q05586 | Glutamate (NMDA) Receptor Subunit Zeta 1, Human | 9800 | 0.58 | Binding ≤ 10μM |
NMDZ1_RAT | P35439 | Glutamate (NMDA) Receptor Subunit Zeta 1, Rat | 9800 | 0.58 | Binding ≤ 10μM |
Z104302 | Z104302 | Glutamate NMDA Receptor | 9800 | 0.58 | Binding ≤ 10μM |
GRID1_HUMAN | Q9ULK0 | Glutamate Receptor Delta-1 Subunit, Human | 9800 | 0.58 | Binding ≤ 10μM |
NMD3A_HUMAN | Q8TCU5 | Glutamate [NMDA] Receptor Subunit 3A, Human | 9800 | 0.58 | Binding ≤ 10μM |
NMD3B_HUMAN | O60391 | Glutamate [NMDA] Receptor Subunit 3B, Human | 9800 | 0.58 | Binding ≤ 10μM |
NMDE1_HUMAN | Q12879 | Glutamate [NMDA] Receptor Subunit Epsilon 1, Human | 9800 | 0.58 | Binding ≤ 10μM |
NMDE2_HUMAN | Q13224 | Glutamate [NMDA] Receptor Subunit Epsilon 2, Human | 9800 | 0.58 | Binding ≤ 10μM |
NMDE3_HUMAN | Q14957 | Glutamate [NMDA] Receptor Subunit Epsilon 3, Human | 9800 | 0.58 | Binding ≤ 10μM |
NMDE4_HUMAN | O15399 | Glutamate [NMDA] Receptor Subunit Epsilon 4, Human | 9800 | 0.58 | Binding ≤ 10μM |
Description | Species |
---|---|
CREB phosphorylation through the activation of CaMKII | |
EPHB-mediated forward signaling | |
Ras activation uopn Ca2+ infux through NMDA receptor | |
Unblocking of NMDA receptor, glutamate binding and activation |
No pre-computed analogs available. Try a structural similarity search.